TARRYTOWN, N.Y., Aug. 29 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS) today announced that Michael R. Garone has been appointed to the position of Chief Financial Officer (CFO). Mr. Garone previously held the role of CFO and Interim Chief Executive Officer of Astralis, Ltd., a biotechnology company. Mr. Garone will report directly to Michael V. Novinski, President and Chief Executive Officer. Emisphere Technologies, Inc. is a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and pharmaceutical compounds using its eligen(R) technology.
"Mr. Garone has over 25 years of highly successful experience as both CFO and CEO, with superior financial skills that promise success for Emisphere," said Mr. Novinski. "His experience with business planning and turn-around, cost control and customer care are among the many skills that he brings to the Company. We are very excited to have him on our senior management team."
At Astralis, Mr. Garone implemented a plan to keep the drug development program on track, and created a system of controls to meet the Sarbanes Oxley Act of 2007, Section 404 compliance objectives. He also worked closely with the United States Securities and Exchange Commission (SEC) and managed assets and investor relations.
Prior to that, Mr. Garone spent two decades at AT&T, where he held a variety of positions, including CFO of AT&T Alascom. While at AT&T Alascom, Mr. Garone managed the acquisition and engineered the business turn-around of Alaska's largest telecommunications company, while providing strategic planning for sales, marketing and product development.
"Joining the team at Emisphere is a terrific opportuni
|SOURCE Emisphere Technologies, Inc.|
Copyright©2007 PR Newswire.
All rights reserved